ML
Matthew L. Posard sold $482K of HALO stock
Matthew L. Posard, Dir of Halozyme Therapeutics, Inc. (HALO), sold 5,000 shares of HALO stock worth $482K, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Nov 18, 2026.
HALO has moved -2.9% since the trade date, from $95.80 to $93.04 (Nov 19, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 0 days
- Price since
- -2.9%
- Role
- Dir
- Source
- SEC Form 4